Elovl6 inhibits colorectal cancer progression through stearic acid–mediated mitochondrial fusion and metabolic reprogramming

Journal:

Science Advances

Published:

2026-02-13

DOI:

10.1126/sciadv.adz2892

Affiliations:

6

Authors:

9

Go to article

Institutions	Authors	Share
State Key Laboratory of Pharmaceutical Biotechnology, NJU, China	6.250000	0.69
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	2.000000	0.22
Nanjing University (NJU), China	0.250000	0.03
Jiangsu Target Pharma Laboratories, Inc., China	0.250000	0.03
Henan Medical University, China	0.250000	0.03

Interested in Medical Biochemistry and Metabolomics?